Skip to main content
David Yang, MD, Pathology, Madison, WI, University Hospital

DavidTYangMD

Pathology Madison, WI

Hematopathology, Anatomic Pathology, Clinical Pathology

Professor, University of Wisconsin

Dr. Yang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yang's full profile

Already have an account?

Education & Training

  • University of Utah Health
    University of Utah HealthFellowship, Hematopathology, 2005 - 2006
  • University of Utah Health
    University of Utah HealthResidency, Pathology-Anatomic and Clinical, 2005
  • Medical University of South Carolina
    Medical University of South CarolinaResidency, Internal Medicine, 1994 - 1997
  • Loma Linda University School of Medicine
    Loma Linda University School of MedicineClass of 1994

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1997 - 2025
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Journal Articles

  • Unique Dependence on Sos1 in KrasG12D-Induced Leukemogenesis  
    David Yang, Erik A Ranheim, Blood
  • Downregulating Notch Counteracts KrasG12D-Induced ERK Activation and Oxidative Phosphorylation in Myeloproliferative Neoplasm  
    Erik A Ranheim, David Yang, Warren S Pear, Lan Zhou, Mignon Loh, Eric Padron, Elliot Stieglitz, Nature

Press Mentions

  • Banking on Patient Samples to Advance COVID-19 Research
    Banking on Patient Samples to Advance COVID-19 ResearchNovember 20th, 2020
  • Researchers Identify Mechanism Controlling Red Blood Cell Development
    Researchers Identify Mechanism Controlling Red Blood Cell DevelopmentOctober 7th, 2016
  • Society of Hematopathology Quarterly Case Winter 2016: Primary Myelofibrosis with an Unusual MPL Mutation: Integrating Molecular Testing into the Diagnosis and Prognosis of BCR-ABL1 Negative Myeloproliferative Neoplasms. WMSH1601
    Society of Hematopathology Quarterly Case Winter 2016: Primary Myelofibrosis with an Unusual MPL Mutation: Integrating Molecular Testing into the Diagnosis and Prognosis of BCR-ABL1 Negative Myeloproliferative Neoplasms. WMSH1601March 3rd, 2016

Hospital Affiliations